Clinical trials: Coats Disease
Heroin Dependence, Amphetamine Dependence
Mirtazapine as a Treatment for Co-Occurring Opioid and ATS Dependence in Malaysia
The purpose of this study is to evaluate tolerability, acceptability and potential efficacy of 4 months of maintenance treatment with Mirtazapine as compared to placebo for patients with co-occurring amphetamine-type stimulant…
- Trial name
- NCT02541526
- Testing
- Mirtazapine
- Where
- Malaysia
- Volunteers
- 80 people
- Sponsor
- Universiti Sains Malaysia
Blood Pressure, Lifestyle Risk Reduction
Blood Pressure Control in ESH Excellence Centres
In the BP-CON-ESH study we are going to include and analyze treated hypertensive patients seen consecutively by the ESH Excellence Centres.
- Conditions
- Blood Pressure, Lifestyle Risk Reduction, White Coat Hypertension
- Trial name
- BP-CON (NCT04295434)
- Where
- 46 sites in Armenia, Austria and 20 more
- Volunteers
- 3,000 people
- Sponsor
- Clinical Hospital Centre Zagreb
White Coat Hypertension, Hypertension
Virtual Reality as a Tool to Lower Blood Pressure and Anxiety in Clinic Settings
This clinical trial aims to evaluate whether a calming virtual reality (VR) experience can reduce office blood pressure (OBP) and anxiety in adults undergoing ambulatory blood pressure monitoring (ABPM) at Mayo Clinic in Florida.
- Conditions
- White Coat Hypertension, Hypertension, Blood Pressure, Anxiety
- Trial name
- NCT06960057
- Testing
- Virtual Reality Exposure
- Where
- United States
- Volunteers
- 79 people
- Sponsor
- Mayo Clinic
Thrombocytopenia
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
The objective of this study is to determine if pooled buffy coat-derived pathogen reduced plasma-stored platelet concentrates are non-inferior compared to plasma-stored platelet concentrates in terms of WHO bleeding complications…
- Trial name
- PREPAReS (NCT02783313)
- Testing
- Pathogen reduced plasma-stored platelet concentrates, Plasma-stored platelet concentrates
- Where
- 10 sites in Canada, Netherlands and 1 more
- Volunteers
- 567 people
- Sponsor
- Sanquin Research & Blood Bank Divisions
Macular Edema Caused by Leber's Miliary Aneurysms
Treatment of Macular Edema Caused by Leber's Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation
This study evaluates the effectiveness of intravitreal Aflibercept (IVA) injection therapy, combined with peripheral laser photocoagulation, in the treatment of macular edema caused by Leber's miliary aneurysm.
- Trial name
- NCT03908723
- Testing
- Panretinal photocoagulation
- Where
- Egypt
- Volunteers
- 6 people
- Sponsor
- Alexandria University
Coats Disease
Coats Plus Syndrome and LCC Syndrome: Series of 10 Pediatric Cases. Review of Literature and Natural History
Coats plus syndrome is a very rare and serious disease, caused by premature telomere shortening. It is a pediatric, multi-systemic disease, the main features of which are retinal vasculopathy and neurological disorders…
- Trial name
- COATS+ (NCT04089995)
- Testing
- data collection
- Where
- 6 sites in France
- Volunteers
- 10 people
- Sponsor
- University Hospital, Limoges
Coats Disease
Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab
This study evaluates the retinal and vascular features in patients affected by Coats disease under the effects of Ranibizumab intravitreal injections using optical coherence tomography and optical coherence tomography angiography
- Trial name
- NCT04310631
- Testing
- Ranibizumab Injection
- Where
- Italy
- Volunteers
- 5 people
- Sponsor
- Federico II University
Essential Hypertension, White Coat Hypertension
Heart Rate Variability in White Coat Hypertension and Essential Hypertension
The aim of the study is to investigate heart rate variability in patients with white coat hypertension and patients with essential hypertension.
- Conditions
- Essential Hypertension, White Coat Hypertension, Healthy
- Trial name
- NCT00286884
- Testing
- Monitoring of heart rate variability
- Where
- Denmark
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- Regional Hospital Holstebro
Hypertension
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Background: Hypertension (high blood pressure) is a major risk factor for heart disease and stroke, yet many people do not know they have it.
- Trial name
- Huawei-SunU1 (NCT07785895)
- Where
- Malaysia
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Sunway University
Coat's Disease
Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)
Congenital Telangiectasia or Coat's disease is an uncommon disorder that involves the growth of blood vessels of the macula. These blood vessels msy extend beneth the retina to produce an area of sub-retinal…
- Trial name
- NCT00211315
- Testing
- anecortave acetate
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Manhattan Eye, Ear & Throat Hospital
Coronary Artery Disease
Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease
COAT-platelets stands for collagen and thrombin stimulated platelets, which are two things in the body that make platelets stick together.
- Trial name
- NCT00229528
- Testing
- Paxil-CR
- Where
- United States
- Volunteers
- 25 people, healthy volunteers welcome
- Sponsor
- University of Oklahoma
Retinal Telangiectasis, Idiopathic Juxtafoveal Retinal Telangiectasia
A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)
This study is conducted to evaluate the safety of THR-317 when administered intravitreally and to assess the compound's efficacy in reducing central subfield thickness (CST) and improving best-corrected visual acuity (BCVA) in…
- Trial name
- NCT03669393
- Testing
- THR-317 8mg
- Where
- 3 sites in France, Switzerland
- Volunteers
- 8 people
- Sponsor
- ThromboGenics
Hypertension,Essential, White Coat Hypertension
Implementing Hypertension Screening Guidelines in Primary Care
The goal of this study is to use a cluster-randomized design (1:1 ratio) among 8 primary care clinics affiliated with New York-Presbyterian Hospital to test the effectiveness of a theory-informed multifaceted implementation…
- Trial name
- EMBRACE (NCT03480217)
- Testing
- Multifaceted Implementation Strategy, Usual care
- Where
- 2 sites in United States
- Volunteers
- 1,186 people
- Sponsor
- Columbia University
Cardiovascular Diseases, Heart Diseases
White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension
To investigate the mechanisms of white coat hypertension and study it further as a risk factor for heart damage.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Trial name
- NCT00005316
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Hypertension, Uncontrolled Hypertension
Use of Automated Office Blood Pressure Monitoring
Blood pressure measurements by three methods Office Blood Pressure Measurement (OBPM), Automated Office Blood Pressure Measurement (AOBPM), and Home Blood Pressure Measurement (HBPM) were collected retrospectively across three…
- Conditions
- Hypertension, Uncontrolled Hypertension, Hypertension, White Coat, Hypertension, Resistant to Conventional Therapy
- Trial name
- NCT05395403
- Testing
- Blood pressure measurement device
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- University of Alabama at Birmingham
Coats' Disease, Idiopathic Retinal Telangiectasia
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy
The purpose of this study is to evaluate the safety and tolerability of intravitreal injections of ranibizumab in the treatment of AMD variants and other choroidal neovascularization (CNV) related conditions (Coats' disease…
- Conditions
- Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Choroidal Vasculopathy
- Trial name
- FVF4140S (NCT00470977)
- Testing
- ranibizumab injection (0.5 mg)
- Where
- 2 sites in United States
- Volunteers
- 18 people
- Sponsor
- Manhattan Eye, Ear & Throat Hospital
Prehypertension
Prehypertension Labeling
The purpose of this study is to find out whether labeling adults with prehypertension has negative effects on clinic blood pressure and quality of life 3 months after diagnosis.
- Trial name
- Tanya K23 (NCT01434953)
- Testing
- Labeled prehypertension, Unlabeled prehypertension
- Where
- United States
- Volunteers
- 100 people, healthy volunteers welcome
- Sponsor
- Columbia University
Dry Eye
The COAT Trial: Cequa's Onset of Action Trial
Cequa's Onset of Action Trial: an Investigation of CEQUA's Speed of Onset in Improving Ocular Surface Health in Dry Eye Patients
- Trial name
- COAT (NCT06482177)
- Testing
- Cyclosporine ophthalmic solution
- Where
- United States
- Volunteers
- 52 people, healthy volunteers welcome
- Sponsor
- Research Insight LLC
Asthma, Chronic Obstructive Pulmonary Disease (COPD)
Chest Wall Oscillation for Asthma and COPD Exacerbations Trial (COAT)
The objective of this study was to evaluate the use of high frequency chest wall oscillation (HFCWO) early in the treatment of adults hospitalized for acute asthma or chronic obstructive pulmonary disease (COPD).
- Conditions
- Asthma, Chronic Obstructive Pulmonary Disease (COPD), Undifferentiated Asthma/COPD
- Trial name
- NCT00181285
- Testing
- High Frequency Chest Wall Oscillator
- Where
- United States
- Volunteers
- 52 people
- Sponsor
- University of Chicago